Vertigon

Vertigon

cinnarizine

Manufacturer:

Geno

Distributor:

Nebula

Marketer:

Mascots
Concise Prescribing Info
Contents
Cinnarizine
Indications/Uses
Control of vestibular symptoms (peripheral & central origin) & of labyrinthine disorders including vertigo, dizziness, tinnitus, nystagmus, nausea & vomiting; prophylaxis of motion sickness; adjunct therapy for symptoms of peripheral arterial disease.
Dosage/Direction for Use
Peripheral circulatory disorders Adult & childn >12 yr 50-75 mg tds. Disorders of balance 25 mg 3 tds. Max: 225 mg daily. Motion sickness Adult 25 mg 2 hr before travel & 12.5-25 mg may be repeated every 8 hr during travel when  necessary. Childn 8-12 yr 12.5 mg tds when necessary, 5-7 yr 6.25 mg tds when necessary.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Parkinson's disease.
Special Precautions
May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Sedation, inability to concentrate, lassitude, dizziness, incoordination, GI disturbances eg nausea, vomiting, diarrhoea, constipation, anorexia, increased appetite, epigastric pain, somnolence, blurred vision, difficulty in micturition, dysuria, dry mouth, tightness of chest, muscular weakness, headache, euphoria, wt gain, perspiration, allergic reactions.
Drug Interactions
CNS depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, TCAs, sedatives & tranquilisers. MAOIs.
MIMS Class
Antivertigo Drugs / Peripheral Vasodilators & Cerebral Activators
ATC Classification
N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.
Presentation/Packing
Form
Vertigon tab 25 mg
Packing/Price
4 × 5 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in